Search Results - "van Spronsen, D J"

Independent prognostic effect of co-morbidity in lymphoma patients: Results of the population-based Eindhoven Cancer Registry by van Spronsen, D.J., Janssen-Heijnen, M.L.G., Lemmens, V.E.P.P., Peters, W.G., Coebergh, J.W.W.

“…The prevalence of co-morbidity among elderly lymphoma patients is associated with a decrease in the use of chemotherapy. This study assessed the independent…”
Get full text

Conditional survival for long-term colorectal cancer survivors in the Netherlands: who do best? by van Erning, F.N, van Steenbergen, L.N, Lemmens, V.E.P.P, Rutten, H.J.T, Martijn, H, van Spronsen, D.J, Janssen-Heijnen, M.L.G

“…Abstract Aim With the increase in the number of long-term colorectal cancer (CRC) survivors, there is a growing need for subgroup-specific analysis of…”
Get full text

Novel treatment strategies in clear-cell metastatic renal cell carcinoma by van Spronsen, D. J, de Weijer, K. J. M, Mulders, P. F. A, De Mulder, P. H. M

“…Metastatic renal-cell carcinoma (mRCC) is highly resistant to cytotoxic agents or hormones and is currently mainly treated with cytokine-based therapy…”
Get full text

Treatment and complications in elderly stage III colon cancer patients in the Netherlands by Hoeben, K.W.J., van Steenbergen, L.N., van de Wouw, A.J., Rutten, H.J., van Spronsen, D.J., Janssen-Heijnen, M.L.G.

“…We evaluated which patient factors were associated with treatment tolerance and outcome in elderly colon cancer patients. Population-based data from five…”
Get full text

Novel treatments for metastatic renal cell carcinoma by van Spronsen, D.J., Mulders, P.F.A., De Mulder, P.H.M.

“…The mainstay of any curative treatment in renal cell carcinoma (RCC) is surgery. In case of metastatic disease at presentation a radical nephrectomy is…”
Get full text

Small but significant excess mortality compared with the general population for long-term survivors of breast cancer in the Netherlands by Janssen-Heijnen, M.L.G., van Steenbergen, L.N., Voogd, A.C., Tjan-Heijnen, V.C.G., Nijhuis, P.H., Poortmans, P.M., Coebergh, J.W.W., van Spronsen, D.J.

“…Coinciding with the relatively good and improving prognosis for patients with stage I–III breast cancer, late recurrences, new primary tumours and late…”
Get full text

A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin capecitabine chemotherapy in colon cancer patients by Lesterhuis, W J, de Vries, I J M, Aarntzen, E A, de Boer, A, Scharenborg, N M, van de Rakt, M, van Spronsen, D-J, Preijers, F W, Figdor, C G, Adema, G J, Punt, C J A

“…Background: Dendritic cell (DC) vaccination has been shown to induce anti-tumour immune responses in cancer patients, but so far its clinical efficacy is…”
Get full text

Need for early recognition and therapeutic guidelines of congenital sideroblastic anaemia by Cuijpers, M. L. H., van Spronsen, D. J., Muus, P., Hamel, B. C. J., Swinkels, D. W.

“…We present a patient with iron overload, who was initially diagnosed with hereditary haemochromatosis. Family analysis, however, established that the iron…”
Get full text

Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphoma by van de Schans, S.A.M., Wymenga, A.N.M., van Spronsen, D.J., Schouten, H.C., Coebergh, J.W.W., Janssen-Heijnen, M.L.G.

“…We investigated treatment of unselected elderly patients with diffuse large B-cell lymphoma (DLBCL) and its subsequent impact on treatment tolerance and…”
Get full text

Doxorubicin/cyclophosphamide with concurrent versus sequential docetaxel as neoadjuvant treatment in patients with breast cancer by Vriens, B.E.P.J, Aarts, M.J.B, de Vries, B, van Gastel, S.M, Wals, J, Smilde, T.J, van Warmerdam, L.J.C, de Boer, M, van Spronsen, D.J, Borm, G.F, Tjan-Heijnen, V.C.G

“…Abstract Background This study was designed to determine whether delivering neo-adjuvant chemotherapy at a higher dose in a shorter period of time improves…”
Get full text

Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma by Geurts, Y.M., Neppelenbroek, S.I.M., Aleman, B.M.P., Janus, C.P.M., Krol, A.D.G., van Spronsen, D.J., Plattel, W.J., Roesink, J.M., Verschueren, K.M.S., Zijlstra, J.M., Koene, H.R., Nijziel, M.R., Schimmel, E.C., de Jongh, E., Ong, F., te Boome, L.C.J., van Rijn, R.S., Böhmer, L.H., Ta, B.D.P., Visser, H.P.J., Posthuma, E.F.M., Bilgin, Y.M., Muller, K., van Kampen, D., So-Osman, C., Vermaat, J.S.P., de Weijer, R.J., Kersten, M.J., van Leeuwen, F.E., Schaapveld, M.

“…The introduction of rituximab significantly improved the prognosis of diffuse large B-cell lymphoma (DLBCL), emphasizing the importance of evaluating the…”
Get full text

Better survival in patients with metastasised kidney cancer after nephrectomy: A population-based study in the Netherlands by Aben, K.K.H, Heskamp, S, Janssen-Heijnen, M.L, Koldewijn, E.L, van Herpen, C.M, Kiemeney, L.A, Oosterwijk, E, van Spronsen, D.J

“…Abstract Aim Cytoreductive nephrectomy is considered beneficial in patients with metastasised kidney cancer but only a minority of these patients undergo…”
Get full text

Minimal excess mortality for long-term colon cancer survivors in the Netherlands 1989–2008 by van Steenbergen, L.N, Steur, M, Lemmens, V.E.P.P, Rutten, H.J.T, van Spronsen, D.J, Janssen-Heijnen, M.L.G

“…Abstract We determined conditional 5-year relative survival rates for colon cancer patients, according to age, gender and tumour stage for each additional year…”
Get full text

Validation, revision and extension of the Follicular Lymphoma International Prognostic Index (FLIPI) in a population-based setting by van de Schans, S.A.M., Steyerberg, E.W., Nijziel, M.R., Creemers, G.-J., Janssen-Heijnen, M.L., van Spronsen, D.J.

“…The aim of this study was to validate the Follicular Lymphoma International Prognostic Index (FLIPI) in a population-based cohort and to study the relevance of…”
Get full text

Prevalence of co-morbidity and its relationship to treatment among unselected patients with Hodgkin's disease and non-Hodgkin's lymphoma, 1993-1996 by VAN SPRONSEN, D. J, JANSSEN-HEIJNEN, M. L. G, BREED, W. P. M, COEBERGH, J. W. W

“…A population-based series of patients with cancer is likely to comprise more patients with serious co-morbidity than clinical trials because of restrictive…”
Get full text

No improvement in renal cell carcinoma survival: A population-based study in the Netherlands by Aben, K.K.H, Luth, T.K, Janssen-Heijnen, M.L.G, Mulders, P.F, Kiemeney, L.A, van Spronsen, D.J

“…Abstract Background The increased finding of kidney ‘incidentalomas’ and more frequent surgery in patients with renal cell cancer (RCC) metastases may have…”
Get full text

Leptomeningeal carcinomatosis in relapsed non-seminoma testis: a 1-year complete remission with high-dose chemotherapy by Denissen, N. H. A. M, van Spronsen, D. J, Smilde, T. J, De Mulder, P. H. M

“…A 1-year complete remission could be achieved with high-dose systemic chemotherapy in a 33-year-old patient with relapsed germ cell tumor presenting with…”
Get full text

Clinical drug-resistant nodular sclerosing Hodgkin's lymphoma is associated with decreased bcl-2 expression in the surrounding lymphocytes and with increased bcl-2 expression in the Reed-Sternberg cells by Van Spronsen, D J, Peh, S C, Vrints, L W, Van Imhoff, G W, Poppema, S

“…Identification of patients with Hodgkin's lymphoma who are primary refractory to chemotherapy will have great impact on treatment planning. Several studies…”
Get full text

New developments in staging and follow-up of patients with Hodgkin's lymphoma by VAN SPRONSEN, D. J, VELDHUIS, G. J

“…Adequate staging of newly diagnosed patients with Hodgkin's lymphoma enables optimal treatment planning, which is of particular importance for finding a…”
Get full text

Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer by Vriens, B. E. P. J., Vriens, I. J. H., Aarts, M. J. B., van Gastel, S. M., van den Berkmortel, F. W. P. J., Smilde, T. J., van Warmerdam, L. J. C., van Spronsen, D. J., Peer, P. G. M., de Boer, M., Tjan-Heijnen, V. C. G.

“…Purpose The INTENS study was designed to determine whether delivering neoadjuvant chemotherapy at a higher dose in a shorter period of time improves outcome of…”
Get full text